Results 21 to 30 of about 167,870,163 (290)

Impact of Out-of-pocket Costs on Varenicline Utilization and Persistence [PDF]

open access: yesJournal of Health Economics and Outcomes Research, 2014
Background: Varenicline is a smoking cessation medication. Objectives: We analyzed patients’ out-of-pocket costs and utilization of and persistence with varenicline. Methods: De-identified claims data in the MarketScan® Commercial Claims and Encounters Database were analyzed retrospectively.
Aaron Galaznik   +5 more
openaire   +3 more sources

Households' out‐of‐pocket expenditure for healthcare in Bangladesh: A health financing incidence analysis [PDF]

open access: yes, 2021
Background: Despite improvements in many health indicators, providing access to affordable healthcare remains a considerable challenge in Bangladesh. Financing incidence analysis will enable an evaluation of how well the healthcare system performs to ...
Khorshed Alam   +19 more
core   +1 more source

Out-of-Pocket Expenditures of Myocardial Infarction Patients in Pondicherry, South India [PDF]

open access: yesJournal of Evidence Based Health Policy, Management & Economics, 2023
Background: Myocardial infarction (MI) is a leading cause of morbidity and mortality worldwide. In India, incidence of MI is rapidly increasing due to lifestyle changes, ageing and rising healthcare costs. The out-of-pocket expenditure (OOPE) for MI care
Chandar Sahanaa   +4 more
doaj  

The out of pocket cost of breast cancer survivors: a review [PDF]

open access: yesJournal of Cancer Survivorship, 2010
Out of pocket (OOP) costs add to the burden facing breast cancer survivors but remain an understudied area of costs. Current turbulent economic climate increases the urgency to better understand this burden. Few studies or systematic reviews focus on OOP costs.PubMed search was conducted for articles in English containing: (1) MESH terms breast ...
Maria, Pisu   +5 more
openaire   +2 more sources

Chronic disease costs from a patient’s perspective: A survey of patients with stroke, heart disease, and chronic kidney disease visiting a district hospital in Indonesia [PDF]

open access: yesJournal of Pharmacy & Pharmacognosy Research
Context: Chronic disease treatment can lead to catastrophic costs. Although most direct medical costs are covered by the National Health Insurance, direct nonmedical and indirect costs may be burdensome for patients.
Dwi Endarti   +5 more
doaj   +1 more source

Economic burden of tuberculosis in Tanzania: a national survey of costs faced by tuberculosis-affected households

open access: yesBMC Public Health, 2022
Background Although tuberculosis (TB) care is free in Tanzania, TB-associated costs may compromise access to services and treatment adherence resulting in poor outcomes and increased risk of transmission in the community.
Andrew Martin Kilale   +17 more
doaj   +1 more source

Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Sacubitril/valsartan improves health outcomes for heart failure with reduced ejection fraction relative to angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers, but it carries higher out‐of‐pocket costs. Neither the impact
Birju R. Rao   +11 more
doaj   +1 more source

Patient-Physician Communication About Out-of-Pocket Costs [PDF]

open access: yesJAMA, 2003
Out-of-pocket costs account for approximately one fifth of health care expenditures and are increasing. Previous research suggests that these costs are associated with medication nonadherence and considerable economic burden among some patients. Little is known about patient-physician communication regarding these costs.To identify patients' and ...
G Caleb, Alexander   +2 more
openaire   +2 more sources

Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States

open access: yes, 2023
Out-of-pocket (OOP) costs may constitute a substantial financial burden to patients diagnosed with cancer. Earlier stage diagnosis and treatment of cancers may promote decreased morbidity and mortality, subsequently also lowering costs.
Ela Fadli (6874868)   +3 more
core   +1 more source

Out‐of‐pocket costs associated with head and neck cancer treatment [PDF]

open access: yesCancer Reports, 2021
AbstractBackgroundOut‐of‐pocket costs (OOPC) associated with treatment have significant implications on quality of life and survival in cancer patients. Head and neck cancer patients face unique treatment‐related challenges, but to date OOPC have been understudied in this population.AimsThis study aims to identify and measure OOPC for patients with ...
Mohemmed N. Khan   +15 more
openaire   +5 more sources

Home - About - Disclaimer - Privacy